US2016310523A1PendingUtilityA1
Use of oxygen-containing gas source
Est. expiryApr 23, 2035(~8.7 yrs left)· nominal 20-yr term from priority
Inventors:Wei-Ta Lai (Ted Lai)
A61P 9/00A61P 43/00A61K 33/00A61K 45/06A61P 25/00A61K 9/007
36
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of increasing blood-brain barrier permeability of a subject to a molecule is disclosed. The method includes causing the subject to inhale a gas source, and the gas source being effective for increasing blood-brain barrier permeability to the molecule, wherein the gas source includes at least 20 weight percent oxygen.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of increasing blood-brain barrier permeability of a subject to a molecule, the method comprising causing the subject to inhale a gas source that is effective for increasing blood-brain barrier permeability to the molecule, wherein the gas source comprises at least 20 weight percent oxygen.
2 . The method of claim 1 , wherein the gas source further comprises at least 1 weight percent carbon dioxide.
3 . The method of claim 2 , wherein a ratio of a weight/volume percent of the oxygen to the weight/volume percent of the carbon dioxide ranges from 1:1 to 1:20.
4 . The method of claim 2 , wherein the gas source comprises 20 weight percent oxygen and 1 weight percent carbon dioxide.
5 . The method of claim 2 , wherein the gas source comprises 20 weight percent oxygen and 20 weight percent carbon dioxide.
6 . The method of claim 2 , wherein the gas source consists of 95 weight percent oxygen and 5 weight percent carbon dioxide.
7 . The method of claim 2 , wherein the gas source consists of 90 weight percent oxygen and 10 weight percent carbon dioxide.
8 . The method of claim 2 , wherein the gas source consists of 80 weight percent oxygen and 20 weight percent carbon dioxide.
9 . The method of claim 1 , wherein the gas source is 100 weight percent oxygen.
10 . The method of claim 1 , wherein the molecule is a diagnostic agent.
11 . The method of claim 1 , wherein the molecule is a neuropharmaceutical agent.Join the waitlist — get patent alerts
Track US2016310523A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.